Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation

(2015) Milton Maciel et al.   PLoS Neglected Tropical Diseases

MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines

(2014) P. J. Holst et al.   JOURNAL OF IMMUNOLOGY

CD8+T Cells Complement Antibodies in Protecting against Yellow Fever Virus

(2014) Maria R. Bassi et al.   JOURNAL OF IMMUNOLOGY

Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial

(2014) Uzma N. Sarwar et al.   PLoS One

Adenovirus-Based Vaccine against Listeria monocytogenes: Extending the Concept of Invariant Chain Linkage

(2013) S. Jensen et al.   JOURNAL OF IMMUNOLOGY

Pre-Existing Vector Immunity Does Not Prevent Replication Deficient Adenovirus from Inducing Efficient CD8 T-Cell Memory and Recall Responses

(2012) Maria Abildgaard Steffensen et al.   PLoS One

Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

(2012) S. Colloca et al.   Science Translational Medicine

Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man

(2012) E. Barnes et al.   Science Translational Medicine

Malaria vaccines: Focus on adenovirus based vectors

(2012) Nathaniel J. Schuldt et al.   VACCINE

Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain

(2011) M. Mikkelsen et al.   JOURNAL OF IMMUNOLOGY

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans

(2010) Andrew J. Bett et al.   VACCINE

Is it time for a new yellow fever vaccine?

(2010) Edward B. Hayes   VACCINE

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

Yellow fever vaccine—how does it work and why do rare cases of serious adverse events take place?

(2009) Alan DT Barrett et al.   CURRENT OPINION IN IMMUNOLOGY

Pressure-inactivated yellow fever 17DD virus: Implications for vaccine development

(2008) Luciane P. Gaspar et al.   JOURNAL OF VIROLOGICAL METHODS

Comparison of multiple vaccine vectors in a single heterologous prime-boost trial

(2008) Brice Barefoot et al.   VACCINE